🔗 Permalink

Inventor profile of:

Scott J. Hecker

City:

Del Mar, California

Country:

United States

Published Applications:

Last publication date:

2025-02-27

Top Assignees for applications by Scott J. Hecker

The entities that hold a legal rights for patent applications filed by inventor Hecker Scott J.:

METABASIS THERAPEUTICS, INC. 10 La Jolla, CA United States
Qpex Biopharma, Inc. 8 San Diego, CA United States
Metabasis Therapeutics, Inc. 7 San Diego, CA United States
MELINTA SUBSIDIARY CORP. 4 Parsippany, NJ United States
Intervet, Inc. 1 Roseland, NJ United States
Ligand Pharmaceuticals Incorporated 1 La Jolla, CA United States
Trine Pharmaceuticals, Inc. 1 Waltham, MA United States
MELINTA SUBSIDIARY CORP. 1 Morristown, NJ United States
Schering-Plough Animal Health Corp. 1 Union, NJ United States

Recent patent applications by Hecker Scott J.

Scott J. Hecker from Del Mar, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-02-27

US20250064838A1

Human necessities

THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVES

#2 | 2025-02-13

US20250049820A1

Human necessities

TETRACYCLINE COMPOSITIONS

#3 | 2025-01-30

US20250034175A1

Chemistry; metallurgy

BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF

#4 | 2025-01-02

US20250002508A1

Chemistry; metallurgy

BORONIC ACID DERIVATIVES AND SYNTHESIS, POLYMORPHIC FORMS, AND THERAPEUTIC USES THEREOF

#5 | 2024-09-19

US20240307422A1

Human necessities

BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF

#6 | 2024-08-22

US20240279248A1

Chemistry; metallurgy

SYNTHESIS OF BORONATE ESTER DERIVATIVES AND USES THEREOF

#7 | 2024-06-13

US20240189326A1

Human necessities

Tetracycline compositions

#8 | 2023-09-07

US20230277571A1

Human necessities

Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

#9 | 2023-05-18

US20230151029A1

Chemistry; metallurgy

BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF

#10 | 2022-04-28

US20220125813A1

Human necessities

Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

#11 | 2022-02-24

US20220056055A1

Chemistry; metallurgy

Boronic acid derivatives and therapeutic uses thereof

#12 | 2021-11-25

US20210361682A1

Human necessities

Boronic acid derivatives and therapeutic uses thereof

#13 | 2020-12-31

US20200407373A1

Chemistry; metallurgy

Boronic acid derivatives and synthesis thereof

#14 | 2020-10-01

US20200308197A1

Chemistry; metallurgy

Synthesis of boronate ester derivatives and uses thereof

#15 | 2020-07-16

US20200222434A1

Human necessities

Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

#16 | 2020-06-11

US20200181177A1

Chemistry; metallurgy

Boronic acid derivatives and therapeutic uses thereof

#17 | 2019-10-31

US20190330144A1

Chemistry; metallurgy

Glucagon antagonists

#18 | 2019-08-01

US20190233443A1

Chemistry; metallurgy

Boronic acid derivatives and therapeutic uses thereof

#19 | 2019-07-18

US20190218176A1

Chemistry; metallurgy

Antagonists of the glucagon receptor

#20 | 2019-05-02

US20190127396A1

Chemistry; metallurgy

SYNTHESIS OF BORONATE ESTER DERIVATIVES AND USES THEREOF

#21 | 2018-10-25

US20180303856A1

Human necessities

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#22 | 2018-01-25

US20180022695A1

Chemistry; metallurgy

Glucagon antagonists

#23 | 2018-01-04

US20180002351A1

Chemistry; metallurgy

Boronic acid derivatives and therapeutic uses thereof

#24 | 2017-09-28

US20170275246A1

Chemistry; metallurgy

Antagonists of the glucagon receptor

#25 | 2016-09-15

US20160263132A1

Human necessities

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#26 | 2016-01-14

US20160009639A1

Chemistry; metallurgy

Antagonists of the glucagon receptor

#27 | 2015-06-18

US20150166590A1

Chemistry; metallurgy

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#28 | 2015-03-26

US20150087680A1

Chemistry; metallurgy

Glucagon antagonists

#29 | 2014-05-15

US20140135400A1

Chemistry; metallurgy

Antagonists of the glucagon receptor

#30 | 2013-01-31

US20130030029A1

Chemistry; metallurgy

Glucagon antagonists

#31 | 2012-10-25

US20120270842A1

Human necessities

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#32 | 2012-08-23

US20120214769A1

Chemistry; metallurgy

Antagonists of the glucagon receptor

#33 | 2012-02-23

US20120046364A1

Chemistry; metallurgy

Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use

#34 | 2012-02-16

US20120039845A1

Chemistry; metallurgy

NUCLEOSIDE PRODRUGS AND USES THEREOF

#35 | 2010-12-02

US20100305060A1

Chemistry; metallurgy

Nucleoside Prodrugs and Uses Thereof

#36 | 2009-08-20

US20090209481A1

Chemistry; metallurgy

Nucleoside prodrugs and uses thereof

#37 | 2008-06-19

US20080146527A1

Chemistry; metallurgy

Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof

#38 | 2008-03-20

US20080070868A1

Chemistry; metallurgy

Novel Thiazole Inhibitors of Fructose 1,6-bisphosphatase

#39 | 2007-09-27

US20070225259A1

Chemistry; metallurgy

Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase

#40 | 2007-01-25

US20070021387A1

Chemistry; metallurgy

Florfenicol prodrug having improved water solubility

#41 | 2006-01-19

US20060014743A1

Chemistry; metallurgy

Methods of preventing bacterial infections with florfenicol-type antibiotics

#42 | 2005-01-06

US20050004095A1

Chemistry; metallurgy

Carbacephem β-lactam antibiotics

InventorID:

68667 ⎘